Completed PHASE4 INTERVENTIONAL 2-arm NCT00902941

Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline

Reversibility of Olfactory Loss in Patients With Idiopathic Parkinson's Disease Following Treatment With Rasagiline

Sponsor: Technische Universität Dresden

Updated 5 times since 2017 Last updated: Feb 6, 2012 Started: May 31, 2009 Primary completion: Feb 29, 2012 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Parkinson´s Disease, this trial is completed. The trial is conducted by Technische Universität Dresden and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Technische Universität Dresden

Data source: Technische Universität Dresden

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dresden, Germany